Mediclinic International PLC Completion of Successful Refinancing (5342C)

TIDMMDC

RNS Number : 5342C

Mediclinic International PLC

28 June 2016

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

28 June 2016

Mediclinic International plc Completes Successful Refinancing

Mediclinic International plc ("Mediclinic" or the "Company"), a leading international private healthcare group, is pleased to announce completion of the refinancing of the Mediclinic Bridge Facility associated with the Company's combination with Al Noor Hospitals Group plc.

Summary of new facilities:

-- South African senior bank loan totalling ZAR1.2 billion at an interest rate of JIBAR +1.69% with a 3-year term expiring in June 2019

-- South African unsecured preference share funding totalling ZAR1.5 billion at a rate of 73% of the prime overdraft interest rate, with a 4-year term expiring in June 2020

-- United Arab Emirates bank loans of $54.5 million and $100.0 million at an interest rate of LIBOR + 2.75% with respective 4-year and 5-year amortising terms, expiring in June 2020 and May 2021

The remainder of the GBP266 million drawn down from the Mediclinic Bridge Facility has been satisfied by a $64.5 million payment from existing cash resources.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information, please contact:

Company Secretary:

Victoria Dalby

Capita Company Secretarial Services Limited

[phone]

UK:

Liz Morley /Aarti Iyer/Lucy Stewart

Bell Pottinger

[phone]

South Africa:

Tertia Kruger

Mediclinic International

[phone]

Notes:

Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.

Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group based in the UK.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBSGDLIDDBGLI

(END) Dow Jones Newswires

June 28, 2016 10:45 ET (14:45 GMT)